The “survival of the fittest” principle applies to cells in a tissue — rapidly growing and dividing cells are the fit ones. A relatively less fit cell, even if healthy and viable, will be eliminated by its more fit neighbors…
Some patients with non-small cell lung cancer (NSCLC) have changes in the anaplastic lymphoma kinase (ALK) gene, which can drive the development of their cancer. …
Chemotherapy is increasingly used to treat larger operable or advanced breast cancer prior to surgery. Chemotherapy delivered via the placement of a central venous line that remains in place for the duration of treatment can result in pre-operative thromboembolic events, which can require the administration of anticoagulation agents…
This means the type of cell obtained from an individual patient to make pluripotent stem cells, determines what can be best done with them. For example, to repair the lung of a patient with lung disease, it is best to start off with a lung cell to make the therapeutic stem cells to treat the disease, or a breast cell for the regeneration of tissue for breast cancer patients…
Gorlin syndrome causes an increased risk of developing cancers of the skin and, rarely, in the brain. …
Breasts are considered dense if they have a lot of fibrous or glandular tissue but not much fatty tissue. …
The researchers showed that chromosomal instability — which is a hallmark of rapidly dividing cancer cells — makes them stressed and vulnerable to mild metabolic disruption. Metabolism is the normal process by which the body turns food into energy…
“Screening recommendations for this age group continue to be debated,” said Bonnie N. Joe, M.D., Ph.D., associate professor in residence and chief of women’s imaging at University of California, San Francisco (UCSF)…
More than half (53 per cent) of 1,700 people who completed a health questionnaire said they had experienced at least one red-flag cancer ‘alarm’ symptom during the previous three months. But only two per cent of them thought that cancer was a possible cause…
A team led by University of Alberta biochemistry professor David Brindley found that inhibiting the activity of an enzyme called autotaxin decreases early tumour growth in the breast by up to 70 per cent. …